TriSalus Life Sciences, Inc. TLSI Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s total cost of revenue?
- TriSalus Life Sciences, Inc. (TLSI) reported total cost of revenue of $1.23M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s total cost of revenue changed year-over-year?
- TriSalus Life Sciences, Inc.'s total cost of revenue decreased by 17.7% year-over-year, from $1.5M to $1.23M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s total cost of revenue?
- Over 2 years (2023 to 2025), TriSalus Life Sciences, Inc.'s total cost of revenue has grown at a 63.5% compound annual growth rate (CAGR), from $2.61M to $6.97M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.